Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 619553
Gene Symbol: MIR484
MIR484
0.020 Biomarker disease BEFREE To reveal the detail mechanism of miR-484 on myocardial ischemia-reperfusion (MI/R) injury. 31845557 2020
Entrez Id: 378938
Gene Symbol: MALAT1
MALAT1
0.040 Biomarker disease BEFREE LncRNA MALAT1 knockdown alleviates myocardial apoptosis in rats with myocardial ischemia-reperfusion through activating PI3K/AKT signaling pathway. 31841208 2019
Entrez Id: 100
Gene Symbol: ADA
ADA
0.030 AlteredExpression disease BEFREE Serum adenosine deaminase activity and coronary artery disease: a retrospective case-control study based on 9929 participants. 31839921 2019
Entrez Id: 7442
Gene Symbol: TRPV1
TRPV1
0.020 AlteredExpression disease BEFREE Transient receptor potential vanilloid type 1 (TRPV1)is highly expressed in cardiac sensory neurons and has a crucial role in detecting myocardial ischemia. 31836538 2020
Entrez Id: 345
Gene Symbol: APOC3
APOC3
0.400 Biomarker disease BEFREE Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease. 31836003 2019
Entrez Id: 116519
Gene Symbol: APOA5
APOA5
0.400 Biomarker disease BEFREE Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease. 31836003 2019
Entrez Id: 718
Gene Symbol: C3
C3
0.020 GeneticVariation disease BEFREE Complement C3 gene polymorphisms are associated with lipid levels, but not the risk of coronary artery disease: a case-control study. 31829184 2019
Entrez Id: 2740
Gene Symbol: GLP1R
GLP1R
0.080 Biomarker disease BEFREE Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure. 31821814 2020
Entrez Id: 6524
Gene Symbol: SLC5A2
SLC5A2
0.060 Biomarker disease BEFREE Differential indication for SGLT-2 inhibitors versus GLP-1 receptor agonists in patients with established atherosclerotic heart disease or at risk for congestive heart failure. 31821814 2020
Entrez Id: 65125
Gene Symbol: WNK1
WNK1
0.030 Biomarker disease BEFREE RNA-sequencing reveals that STRN, ZNF484 and WNK1 add to the value of mitochondrial MT-COI and COX10 as markers of unstable coronary artery disease. 31821324 2019
Entrez Id: 83744
Gene Symbol: ZNF484
ZNF484
0.010 Biomarker disease BEFREE RNA-sequencing reveals that STRN, ZNF484 and WNK1 add to the value of mitochondrial MT-COI and COX10 as markers of unstable coronary artery disease. 31821324 2019
Entrez Id: 100874058
Gene Symbol: COX10-AS1
COX10-AS1
0.010 Biomarker disease BEFREE RNA-sequencing reveals that STRN, ZNF484 and WNK1 add to the value of mitochondrial MT-COI and COX10 as markers of unstable coronary artery disease. 31821324 2019
Entrez Id: 4018
Gene Symbol: LPA
LPA
0.400 Biomarker disease BEFREE In an attempt to improve the effectiveness of therapy, we temporarily shortened treatment intervals of Lp-apheresis in patients with elevated lipoprotein(a) (Lp(a)) and further progression of coronary atherosclerosis despite weekly Lp-apheresis and maximal lipid lowering medication. 31818444 2019
Entrez Id: 5446
Gene Symbol: PON3
PON3
0.030 Biomarker disease BEFREE Paraoxonase 3: Structure and Its Role in Pathophysiology of Coronary Artery Disease. 31816846 2019
Entrez Id: 406938
Gene Symbol: MIR146A
MIR146A
0.400 Biomarker disease BEFREE MicroRNA-146a protects against myocardial ischaemia reperfusion injury by targeting Med1. 31798643 2019
Entrez Id: 55432
Gene Symbol: YOD1
YOD1
0.010 Biomarker disease BEFREE A novel circRNA-miRNA-mRNA network identifies circ-YOD1 as a biomarker for coronary artery disease. 31797949 2019
Entrez Id: 6347
Gene Symbol: CCL2
CCL2
0.600 Biomarker disease BEFREE Effects of crocin and saffron aqueous extract on gene expression of SIRT1, AMPK, LOX1, NF-κB, and MCP-1 in patients with coronary artery disease: A randomized placebo-controlled clinical trial. 31797473 2019
Entrez Id: 6283
Gene Symbol: S100A12
S100A12
0.060 Biomarker disease BEFREE In addition, recent study showed that serum S100A12 can predict future cardiovascular events, highlighting that S100A12 is likely to be a potential biomarker of therapeutic efficacy and disease progression in coronary heart disease. 31794767 2020
Entrez Id: 1950
Gene Symbol: EGF
EGF
0.040 Biomarker disease BEFREE These findings suggest that hypoxia-inducible factor 2A promotes transcription-independent induction of ERBB1 protein and implicates epidermal growth factor signaling in protection from myocardial ischemia and reperfusion injury. 31794514 2020
Entrez Id: 1956
Gene Symbol: EGFR
EGFR
0.030 Biomarker disease BEFREE Myocyte-specific Hif2a or ErbB1 knockout mice were generated to observe the effect of Hif2a knockdown in regulating ERBB1 expression and to examine the role of ERBB1 during myocardial ischemia and reperfusion injury. 31794514 2020
Entrez Id: 2034
Gene Symbol: EPAS1
EPAS1
0.020 AlteredExpression disease BEFREE Myocyte-specific Hif2a or ErbB1 knockout mice were generated to observe the effect of Hif2a knockdown in regulating ERBB1 expression and to examine the role of ERBB1 during myocardial ischemia and reperfusion injury. 31794514 2020
Entrez Id: 374
Gene Symbol: AREG
AREG
0.020 AlteredExpression disease BEFREE Hypoxia-inducible factors are stabilized and provide protection from ischemia and reperfusion injury in the setting of myocardial ischemia.In the setting of ischemia, myocyte-specific hypoxia-inducible factor 2A induces expression of amphiregulin, which is an epidermal growth factor that binds to epidermal growth factor receptor 1 (ERBB1) in the myocardium. 31794514 2020
Entrez Id: 7421
Gene Symbol: VDR
VDR
0.100 GeneticVariation disease BEFREE Diminished 25-OH vitamin D<sub>3</sub> levels and vitamin D receptor variants are associated with susceptibility to type 2 diabetes with coronary artery diseases. 31793694 2019
Entrez Id: 7137
Gene Symbol: TNNI3
TNNI3
0.100 AlteredExpression disease BEFREE Our results showed that miR-206 inhibitor alleviated ischemia-reperfusion-induced arrhythmias, indicated by the lower extent of changes in heart rate (HR), PR interval, rate pressure product (RPP), and mean arterial pressure (MAP). miR-206 inhibitor also downregulated the serum creatine kinase isoenzyme (CKMB) and cardiac troponin I (cTnI) levels in mice under myocardial ischemia-reperfusion (IR) process. 31792806 2019
Entrez Id: 406989
Gene Symbol: MIR206
MIR206
0.030 AlteredExpression disease BEFREE Our results showed that miR-206 inhibitor alleviated ischemia-reperfusion-induced arrhythmias, indicated by the lower extent of changes in heart rate (HR), PR interval, rate pressure product (RPP), and mean arterial pressure (MAP). miR-206 inhibitor also downregulated the serum creatine kinase isoenzyme (CKMB) and cardiac troponin I (cTnI) levels in mice under myocardial ischemia-reperfusion (IR) process. 31792806 2019